New Delhi: Kenvue, the consumer health company that was once part of Johnson & Johnson, has appointed Publicis Media as its official media agency for the Asia-Pacific (APAC) region. This appointment comes after a highly competitive pitch process earlier in 2024, which was managed by global consultancy R3. The account was previously held by IPG.
The Rs 120-crore media pitch marks a significant shift in Kenvue’s media strategy as it seeks to strengthen its presence and consumer reach across multiple countries in the APAC region. Publicis Media will now handle media strategy, planning, and buying for Kenvue, tasked with orchestrating high-impact media campaigns that align with the brand’s consumer health portfolio.
Kenvue’s decision to appoint Publicis Media aligns with its broader transformation goals following its separation from Johnson & Johnson. In May 2024, Kenvue also expanded its global creative agency roster, bringing on board FCB from Interpublic Group and BBDO from Omnicom, further solidifying its efforts to build a stronger and more integrated global marketing ecosystem.
Publicis Media’s appointment is a part of Kenvue’s broader growth strategy following the significant restructuring of Johnson & Johnson in 2021. As part of the restructuring, the company split into two separate entities, with Kenvue emerging as the dedicated consumer health business focused on iconic products such as Band-Aids, Baby Powder, Tylenol, and others.
The company officially adopted the Kenvue brand in September 2022, a name inspired by the combination of “ken,” referring to knowledge, and “vue,” symbolizing vision. This rebranding reflects Kenvue’s mission to bring greater clarity and understanding to the consumer health space.
With Publicis Media now onboard, Kenvue aims to enhance its media strategies across a rapidly evolving digital landscape in APAC, ensuring that its brands continue to resonate with today’s health-conscious consumers.
